Denali Therapeutics (DNLI) Enterprise Value Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.75% |
| Dec 31, 2025 | -4.27% |
| Sep 30, 2025 | -1.39% |
| Jun 30, 2025 | -0.32% |
| Mar 31, 2025 | 12.70% |
| Dec 31, 2024 | 19.54% |
| Sep 30, 2024 | 24.58% |
| Jun 30, 2024 | 24.76% |
| Mar 31, 2024 | 27.29% |
| Dec 31, 2023 | 22.58% |
| Sep 30, 2023 | -0.29% |
| Jun 30, 2023 | -11.45% |
| Mar 31, 2023 | -34.56% |
| Dec 31, 2022 | -54.40% |
| Sep 30, 2022 | -6.44% |
| Jun 30, 2022 | 18.36% |
| Mar 31, 2022 | 32.24% |
| Dec 31, 2021 | 41.12% |
| Sep 30, 2021 | -8.11% |
| Jun 30, 2021 | -138.17% |
| Mar 31, 2021 | -140.64% |
| Dec 31, 2020 | -253.84% |
| Sep 30, 2020 | -100.51% |
| Jun 30, 2020 | -14.83% |
| Mar 31, 2020 | -20.96% |
| Dec 31, 2019 | 10.54% |
| Sep 30, 2019 | -27.85% |
| Jun 30, 2019 | -28.45% |
| Mar 31, 2019 | -30.02% |
| Dec 31, 2018 | -14.30% |
| Sep 30, 2018 | -933.83% |
| Jun 30, 2018 | -802.00% |
| Mar 31, 2018 | -916.03% |